These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30212830)

  • 1. Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy.
    Liu F; Zhang S; Xu R; Gao S; Yin J
    Kidney Blood Press Res; 2018; 43(5):1425-1436. PubMed ID: 30212830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy.
    Peng H; Li Y; Wang C; Zhang J; Chen Y; Chen W; Cao J; Wang Y; Hu Z; Lou T
    Sci Rep; 2016 Feb; 6():20304. PubMed ID: 26842599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum response factor induces endothelial-mesenchymal transition in glomerular endothelial cells to aggravate proteinuria in diabetic nephropathy.
    Zhao L; Zhao J; Wang X; Chen Z; Peng K; Lu X; Meng L; Liu G; Guan G; Wang F
    Physiol Genomics; 2016 Oct; 48(10):711-718. PubMed ID: 27565710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
    Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T
    PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy.
    Guan G; Xie J; Dai Y; Han H
    J Biol Chem; 2022 Mar; 298(3):101725. PubMed ID: 35157852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2 promotes endothelial-to-mesenchymal transition of glomerular endothelial cells via MEK/ERK signaling pathway in diabetic nephropathy.
    Shang J; Zhang Y; Jiang Y; Li Z; Duan Y; Wang L; Xiao J; Zhao Z
    Biochem Biophys Res Commun; 2017 Mar; 484(2):435-441. PubMed ID: 28137583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differentiated embryonic chondrocyte gene 2 (DEC2) inhibits transdifferentiation of mouse glomerular endothelial cells and renal fibrosis by blocking TGF-β/ROCK1 signaling pathway].
    Yin X; Chen L; Meng F; Jiang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Sep; 39(9):816-823. PubMed ID: 37732577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling.
    Correia AC; Moonen JR; Brinker MG; Krenning G
    J Cell Sci; 2016 Feb; 129(3):569-79. PubMed ID: 26729221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes.
    Yasuzawa T; Nakamura T; Ueshima S; Mima A
    J Diabetes Res; 2021; 2021():2182225. PubMed ID: 34977254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
    Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase promotes endothelial-to-mesenchymal transition in diabetic glomerular endothelial cells through mediating ERK signaling.
    Chang K; Xie Q; Niu J; Gu Y; Zhao Z; Li F; Qin Q; Liu X
    Cell Death Discov; 2022 Feb; 8(1):67. PubMed ID: 35173145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
    Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
    Zhang H; Hu J; Liu L
    Biomed Pharmacother; 2017 Nov; 95():215-222. PubMed ID: 28846982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy.
    Lu L; Zhong Z; Gu J; Nan K; Zhu M; Miao C
    Mol Med; 2021 Jul; 27(1):74. PubMed ID: 34238215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of fasudil on the epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells from diabetic rats.
    Wu G; Tu Y; Jia R
    Biomed Pharmacother; 2010 Feb; 64(2):124-9. PubMed ID: 20006464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
    Kanasaki K; Shi S; Kanasaki M; He J; Nagai T; Nakamura Y; Ishigaki Y; Kitada M; Srivastava SP; Koya D
    Diabetes; 2014 Jun; 63(6):2120-31. PubMed ID: 24574044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
    Shi S; Srivastava SP; Kanasaki M; He J; Kitada M; Nagai T; Nitta K; Takagi S; Kanasaki K; Koya D
    Kidney Int; 2015 Sep; 88(3):479-89. PubMed ID: 25830763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose induced endothelial to mesenchymal transition in human umbilical vein endothelial cell.
    Yu CH; Suriguga ; Gong M; Liu WJ; Cui NX; Wang Y; Du X; Yi ZC
    Exp Mol Pathol; 2017 Jun; 102(3):377-383. PubMed ID: 28347704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CLOCK under high glucose upregulates ROCK1-mediated endothelial to mesenchymal transition and aggravates plaque vulnerability.
    Tang H; Zhu M; Zhao G; Fu W; Shi Z; Ding Y; Tang X; Guo D
    Atherosclerosis; 2018 Aug; 275():58-67. PubMed ID: 29860109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.